The demand for emergency care after pulpotomy with Biodentine® on permanent molars with irreversible acute pulpitis: Clinical trial study

Abstract

Introduction: In Endodontology, intra- and postoperative pain control is a key aspect of clinical practice. Such pain can be immediate, deferred, transitional, prolonged, or permanent. This clinical trial was performed to assess the demand for emergency care after pulpotomy on mature permanent molars with clinical signs of irreversible pulpitis. Materials and Methods: Fifty patients aged 15–46 years who had undergone pulpotomy and were prescribed ibuprofen were given cards on which to record the occurrence and intensity of pain on a visual analog scale ranging from 0 (no symptom) to 10 (unbearable pain), and the use of any medication. After 1 week, the patients returned the cards and underwent clinical examination. The patients had clinical and radiographic checkups at months 3 (M3) and 6 (M6), and contacted their practitioners if they required additional appointments for pain relief. Data were statistically analyzed. Results: Examinations were performed on 49 patients on day 7 (D7), 44 patients at M3, and 41 patients at M6. On D7, 42 (85.7%) patients had pain, with an average duration of 2.1 ± 1.3 days and the average intensity of 1.1 ± 0.8. The intensity of pain was significantly greater in patients males (P = 0.013). No patient had pain, discomfort, or irritation between D7 and M3, at M3, or between M3 and M6. At M6, one (2.4%) patient had a broken tooth with pain on chewing and 97.6% of patients were pain-free. Conclusion: Pulpotomy with Biodentine® appears to be appropriate for mature permanent teeth with acute irreversible pulpitis.

Keywords

• biodentine®
• emergency care
• irreversible acute pulpitis
• permanent molar
• pulpotomy